Logo | Name | Σ | ||
---|---|---|---|---|
EMBL The European Molecular Biology Laboratory drives visionary research and technology development in the life sciences. Founded in 1974, EMBL is Europe’s flagship laboratory for the life sciences – an intergovernmental organisation with more than 80 independent research groups covering the spectrum of molecular biology. It operates across six sites: Heidelberg, Barcelona, Hamburg, Grenoble, Rome and EMBL-EBI Hinxton. www.embl.org | www.embl.org/jobs Our mission is to perform basic research in molecular biology; to offer vital services to scientists in the member states; to train scientists, students and visitors at all levels; to develop new instruments and methods in the life sciences and … Sectors: Research | 138 | 98 | 25 | |
Creative Destruction Lab Creative Destruction Lab's mission is to enhance the commercialization of science for the betterment of humankind. Creative Destruction Lab (CDL) is a nonprofit organization that delivers an objectives-based program for massively scalable, seed-stage, science- and technology-based companies. The nine-month program employs an objectives-based mentoring process to enhance the performance of technical founders who learn from the insights of experienced entrepreneurs, with the goal of maximizing equity-value creation. Founded by Professor Ajay Agrawal in 2012 at the University of Toronto’s Rotman School of Management, the program has expanded and now has 11 sites across six countries: Toronto, Vancouver, Calgary, Montreal, Halifax, … Sectors: Startup accelerator & VC | 337 | 209 | 64 | |
AbbVie AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html. Biopharmaceutical, Biotechnology, Innovation, Research and Development, Manufacturing, Biotherapeutics, Oncology, Immunology, Virology, Neuroscience, Womens Health, Aesthetics, and Eye Care Sectors: Pharmaceutical | 924 | 758 | 130 | |
Merck Group This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada. _______________________________ We are Merck, a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, … Tags: DAX30 Sectors: Biotechnology Pharmaceutical | 1468 | 854 | 336 | |
Instituto de Biomecánica (IBV) Innovation in the care of people The Instituto de Biomecánica (IBV) is a leading technological center focused on enhancing products, environments, and services for people's well-being. Founded in 1976 and concerted between the Valencian Institute for Business Competitiveness (IVACE) and the Polytechnic University of Valencia (UPV), IBV is a member of REDIT and part of the Ministerial Network of Units of Scientific Culture and Innovation (UCC+i). We combine knowledge from various sciences and disciplines and apply them to multiple sectors, aiming to improve the quality of life and increase business competitiveness through people’s well-being. Our mission is to transform scientific … | 265 | 102 | 125 | |
Dia & Co The Challenge: 67% of American women wear sizes 14+—that’s 100 million women. Yet this majority is systematically underserved by the retail industry. The plus size community faces paltry options, unwelcoming environments, and a lack of representation—all adding up to a disappointing experience with style. Our Vision: Style freedom through a life well-lived The Dia & Co Solution: Dia & Co is the only retail service dedicated to meeting the plus size community’s full range of style needs. We’re applying the best of data and technology to serve women who have been ignored for far too long—from developing the shopping experiences … Sectors: Semiconductors | 2089 | 1630 | 335 | |
Biogen Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities, to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth. With approximately 7,000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Baar, Switzerland and we … Sectors: Biotechnology | 691 | 481 | 48 | |
Johnson & Johnson At Johnson & Johnson, we believe health is everything. As a focused healthcare company, with expertise in Innovative Medicine and MedTech, we’re empowered to tackle the world’s toughest health challenges, innovate through science and technology, and transform patient care. All of this is possible because of our people. We’re passionate innovators who put people first, and through our purpose-driven culture and talented workforce, we are stronger than ever. Learn more at https://www.jnj.com. Community Guidelines: http://www.jnj.com/social-media-community-guidelines Health Care, Medical Devices & Diagnostics, and Pharmaceuticals Sectors: Pharmaceutical | 4500 | 2867 | 644 | |
Sanofi We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare Tags: CAC40 Sectors: Pharmaceutical | 3444 | 2570 | 830 | |
Astellas Pharma Astellas Pharma is a pharmaceutical company conducting business in approximately 70 countries around the world. At Astellas, we strive to be a cutting-edge, value-driven life science innovator. This means working at the forefront of healthcare change to turn innovative science into the best outcomes for patients. Operating in approximately 70 countries with more than 14,000 employees, we are relentless in our pursuit of scientific progress and in tackling unmet medical needs. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines Pharmaceuticals and 医薬品 Sectors: Pharmaceutical | 107 | 72 | 22 | |
Amazon Web Services (AWS) Official Global LinkedIn page for Amazon Web Services (AWS). Launched in 2006, Amazon Web Services (AWS) began exposing key infrastructure services to businesses in the form of web services -- now widely known as cloud computing. The ultimate benefit of cloud computing, and AWS, is the ability to leverage a new business model and turn capital infrastructure expenses into variable costs. Businesses no longer need to plan and procure servers and other IT resources weeks or months in advance. Using AWS, businesses can take advantage of Amazon's expertise and economies of scale to access resources when their business needs them, … Sectors: IT services | 7357 | 6667 | 139 | |
Xilinx Xilinx is now part of AMD. Follow the AMD LinkedIn page for Xilinx tech updates and job opportunities. Xilinx was founded in Silicon Valley in 1984 and was the inventor of the FPGA and Adaptive SoCs. Xilinx’s highly flexible, programmable silicon, enabled by a suite of advanced software and tools, drove rapid innovation across a wide span of industries and technologies. Xilinx delivered the most dynamic processing technology in the industry, enabling rapid innovation with its adaptable, intelligent computing. In 2022, Xilinx was acquired by AMD and is now the AMD Adaptive and Embedded Computing Group. Follow the AMD LinkedIn … Sectors: Semiconductors | 496 | 278 | 38 |